TEAD4 and in situ carcinoma: Positive TEAD4 staining was commonly observed in carcinoma (87.5%, 7/8), but much less in samples with healthy mucosa (12.5%, 1/8), hyperplasia (25.0%, 2/8) or dysplasia/carcinoma in situ (37.5%, 3/8).